SAM
ABUS icon

Secure Asset Management’s Arbutus Biopharma ABUS Stock Holding History

Secure Asset Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$39K – 204
2021
Q4 		$39K Hold
10,000
– – 0.02% 206
2021
Q3 		$43K Hold
10,000
– – 0.02% 180
2021
Q2 		$30K Hold
10,000
– – 0.02% 182
2021
Q1 		$33K Hold
10,000
– – 0.02% 177
2020
Q4 		$36K Hold
10,000
– – 0.02% 152
2020
Q3 		$31K Hold
10,000
– – 0.02% 141
2020
Q2 		$18K Hold
10,000
– – 0.01% 151
2020
Q1 		$10K Hold
10,000
– – 0.01% 112
2019
Q4 		$28K Buy
+10,000
New +$16.2K 0.02% 158

Other funds holding ABUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Secure Asset Management's ABUS Position: Q1 2022 in Review

Secure Asset Management sold out of Arbutus Biopharma (ABUS) in Q1 2022, closing a stake of 10,000 shares — an estimated $39K sold.

Secure Asset Management first reported a position in ABUS in Q4 2019 and held it in 9 quarters. The position peaked at $43K in Q3 2021. 119 funds tracked by Wall St. Rank hold ABUS as of Q1 2022.

  • Secure Asset Management reported no remaining Arbutus Biopharma position as of Q1 2022 after selling out during the quarter.
  • Secure Asset Management sold 10,000 Arbutus Biopharma shares in Q1 2022, an estimated $39K.
  • Secure Asset Management first reported a position in Arbutus Biopharma in Q4 2019 and held it in 9 quarters.
  • Secure Asset Management's Arbutus Biopharma position peaked at $43K in Q3 2021.
  • 119 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2022.

Based on Secure Asset Management's 13F filing for Q1 2022, filed 19 Apr 2022.